ELI LILLY & Co (LLY) vs Oklo Inc.(OKLO)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | LLY | OKLO |
|---|---|---|
| Sector | Health Care | Utilities |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $65.18B | — |
| Revenue growth (YoY) | ▲ 44.7% | — |
| Net income | $20.64B | -$105.66M |
| Gross margin | — | — |
| Diluted EPS | $22.95 | $-0.72 |
| Insider net (6 mo) | −31.0K sh · 5 sells · 0 buys | +2.1M sh · 71 sells · 0 buys |
| Institutional owners | 51 | 42 |
| Institutional value held | $533.23B | $3.64B |
| Next earnings (est.) | Around Oct 29, 2026 | — |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About ELI LILLY & Co (LLY)
Eli Lilly and Company, incorporated in Indiana in 1901 and tracing its roots to a drug manufacturing business founded in 1876, operates as a single-segment human pharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative
About Oklo Inc. (OKLO)
Oklo Inc., founded in 2013, is developing next-generation fast fission nuclear power plants called "Aurora powerhouses" designed to produce 15-75 megawatts electric (with potential expansion to 100 MWe and higher) using fresh, recycled, or down-blended nuclear
Source: SEC EDGAR.